Skip to main content
. 2013 Jan 21;34(3):380–386. doi: 10.1038/aps.2012.160

Table 1. Uterine index and serum E2, FSH, and LH levels in E2- or ICS-treated rats. Results are means±SEM. n=8 rats/group. bP<0.05, cP<0.01 vs Sham-Veh group. eP<0.05, fP<0.01 vs OVX-Veh group.

Treatment Uterine index (mg/g×100) Level in serum
17β-Estradiol (pg/mL) FSH (mIU/mL) LH (mIU/mL)
Sham-Veh 287.0±16.0 24.5±1.9 1.8±0.2 1.2±0.2
OVX-Veh 136.7±12.0c 13.1±0.8c 3.3±0.3c 2.9±0.1c
OVX+E2 196.3±71.0f 22.1±0.5e 2.2±0.5e 1.3±0.1e
OVX+ICS-20 150.8±27.6 17.6±0.7 2.6±0.3 2.4±0.3
OVX+ICS-50 180.1±21.4e 18.5±1.6e 2.5±0.4e 2.2±0.4e
OVX+ICS-100 186.1±11.3e 19.4±1.1e 2.4±0.6e 1.5±0.1f

Sham-Veh: Sham operated and vehicle treated group; OVX-Veh: Ovariectomized and vehicle treated group; OVX+E2: OVX and E2 (0.25 mg·kg−1·d−1, ig) treated group; OVX+ICS-20; OVX and ICS (20 mg·kg−1·d−1, ig) treated group; OVX+ICS-50: OVX and ICS (50 mg·kg−1·d−1, ig) treated group; and OVX+ICS-100: OVX and ICS (100 mg·kg−1·d−1, ig) treated group.